Nearly 30,000 delegates are expected at the Paris Convention Centre and other pavilions of Paris Expo Porte de Versailles Paris from 17 to 21 September 2021.
It will be the first time that ESMO, a leading European organisation for oncology professionals, holds its congress at the venue.
The ESMO 2021 program will be developed by a committee of more than 300 international experts.
It will include standard research as well as the latest discoveries in immunotherapy of cancer, from oncology nursing to palliative care, rare cancers and the approval of medicines.
The event will feature specialist scientific research, including from Gustave Roussy Cancer Campus Paris.
ESMO chief executive officer Keith McGregor said: "The ESMO Congress has grown dramatically and is now the leading oncology event in Europe, attracting nearly 30,000 clinicians, researchers, oncology nurses, patient advocates, journalists and representatives from the pharmaceutical industry from all over the world."
ESMO is a professional organisation for medical oncology with more than 20,000 members from 150 countries.
Paris Convention Centre
Viparis, a subsidiary of the Paris Ile-de-France Chamber of Commerce and Industry and Unibail-Rodamco-Westfield, manages the ten main event venues in the Greater Paris region.
Pablo Nakhlé Cerruti, CEO of Viparis: "This represents a real vote of confidence for Paris Convention Centre as the home of world leading events. Since its opening a year and a half ago, it has already hosted 13 world conferences, and 30 more are already in the planning stages through 2023."
For more features and breaking news sign up to C&IT Magazine's daily Newstracker.
Have you registered with us yet?
Register now to enjoy more articles
and free email bulletins.